House bill · 119th Congress · Latest step: Introduced
Drug Deal Disclosure Act
Official title: To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.
Open in Bill Explorer →Where it went
- IntroducedJul 15, 2026
- Committee action—
- Passed House—
- Passed Senate—
- To the President—
- Became law—
Latest action: Jul 15, 2026 — Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cost and committee reports
Official records Congress.gov attaches to H.R. 9699.
- Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. CHU, as printed in the Congressional Record (Vol. 172, No. 115, July 15, 2026, Page H4545):Clause 1 of Section 8 of Article I of the ConstitutionSource: Congress.gov, Congressional Record July 15, 2026 ↗
Evidence
- Field in the Congress.gov record
- constitutionalAuthorityStatementText
- Statement length
- 54 characters
- Congress.gov bill record
- H.R. 9699, 119th Congress
- Congress.gov API record
- https://api.congress.gov/v3/bill/119/hr/9699
- Record last updated by Congress.gov
- September 8, 2026
- PORKER copy retrieved
- September 11, 2026
- Stored copy, SHA-256 of the file
25ad1d44941479a3da26e9c31b48d26f9a1e813efa4354580e7180eb9a3dda0b
PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.
Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of September 8, 2026). Not every bill gets one.
From the Congress.gov bill record for H.R. 9699, last updated September 8, 2026. PORKER’s copy was retrieved September 11, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.
Vote results
No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).
Cosponsors
24 cosponsors — 24 Democrats
0 of 24 cosponsors (0%) are from the other party.
Donald Beyer (D-VA), André Carson (D-IN), Kathy Castor (D-FL), Yvette Clarke (D-NY), Suzan DelBene (D-WA), Maxine Dexter (D-OR), Lloyd Doggett (D-TX), Dwight Evans (D-PA), Maggie Goodlander (D-NH), Summer Lee (D-PA), Doris Matsui (D-CA), Betty McCollum (D-MN), Kweisi Mfume (D-MD), Gwen Moore (D-WI), Eleanor Norton (D-DC), Jimmy Panetta (D-CA), Chris Pappas (D-NH), Deborah Ross (D-NC), Janice Schakowsky (D-IL), Bradley Schneider (D-IL), Mark Takano (D-CA), Rashida Tlaib (D-MI), Paul Tonko (D-NY), Nikema Williams (D-GA).
More from the sponsor
Other 119th Congress bills sponsored by Rep. Judy Chu.
- H.R. 754 (119th) Investing in Main Street Act of 2025
- H.R. 7463 (119th) Foster Youth Postsecondary Education Access and Success Act
- H.R. 12 (119th) Women’s Health Protection Act of 2025
- H.R. 4443 (119th) Asunción Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2025
- H.R. 924 (119th) NO BAN Act
- H.R. 4163 (119th) PRIDE Act of 2025
Related bills
- S. 4355 (119th) Drug Deal Disclosure ActRelated bill
Relationships as recorded by Congress.gov.
Sponsor’s state and district
Data as of Sep 25, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.